BOSTON, March 3, 2015 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"), a specialty pharmaceutical company focused on pharmaceuticals for women's health, today announced that it will present at the 27th Annual ROTH Conference, which will take place from March 8-11 at the Ritz-Carlton Laguna Niguel in Dana Point, California. Management's presentation will take place on Wed. March 11 at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) in the Promenade room.
To access a live webcast of the presentation, visit: http://wsw.com/webcast/roth29/cbrx
About Columbia Laboratories
Columbia Laboratories, Inc. has a successful heritage in developing women's health focused pharmaceutical products, including CRINONE® 8% (progesterone gel), that is marketed by Actavis, Inc. in the United States and by Merck Serono S.A. in over 60 additional countries worldwide. Columbia is leveraging its pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to advance an internal pipeline while generating revenue from pharmaceutical industry customers. For more information, please visit www.columbialabs.com.
CRINONE® is a registered trademark of Actavis, Inc. in the United States.
Investor Relations Contact:
MBS Value Partners
+212 661 7004
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/columbia-laboratories-to-present-at-the-27th-annual-roth-conference-300044566.html
SOURCE Columbia Laboratories, Inc.